Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway.

Cell metabolism | 2018

How mitochondrial metabolism is altered by oncogenic tyrosine kinases to promote tumor growth is incompletely understood. Here, we show that oncogenic HER2 tyrosine kinase signaling induces phosphorylation of mitochondrial creatine kinase 1 (MtCK1) on tyrosine 153 (Y153) in an ABL-dependent manner in breast cancer cells. Y153 phosphorylation, which is commonly upregulated in HER2+ breast cancers, stabilizes MtCK1 to increase the phosphocreatine energy shuttle and promote proliferation. Inhibition of the phosphocreatine energy shuttle by MtCK1 knockdown or with the creatine analog cyclocreatine decreases proliferation of trastuzumab-sensitive and -resistant HER2+ cell lines in culture and in xenografts. Finally, we show that cyclocreatine in combination with the HER2 kinase inhibitor lapatinib reduces the growth of a trastuzumab-resistant HER2+ patient-derived xenograft. These findings suggest that activation of the phosphocreatine energy shuttle by MtCK1 Y153 phosphorylation creates a druggable metabolic vulnerability in cancer.

Pubmed ID: 30174304 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Phospho-HER2/ErbB2 (Tyr1248) Antibody (antibody)

RRID:AB_331725

This unknown targets Her2 / ErbB2, phospho (Tyr1248)

View all literature mentions

LC3B (D11) XP Rabbit mAb (antibody)

RRID:AB_2137707

This monoclonal targets LC3B (D11) XP Rabbit mAb

View all literature mentions

Tom40 (D-2) (antibody)

RRID:AB_10847086

This monoclonal targets Tom40 (D-2)

View all literature mentions

Fyn (FYN3) (antibody)

RRID:AB_631528

This polyclonal targets FYN

View all literature mentions

uMtCK (C-8) (antibody)

RRID:AB_10917038

This monoclonal targets uMtCK (C-8)

View all literature mentions

c-Abl (24-11) (antibody)

RRID:AB_626775

This monoclonal targets ABL1, BCR

View all literature mentions

Anti-Ubiquitin Antibody (P4D1) (antibody)

RRID:AB_628423

This monoclonal targets Ubiquitin

View all literature mentions

p-Tyr (PY99) (antibody)

RRID:AB_628123

This monoclonal targets p-Tyr (PY99)

View all literature mentions

c-erbB-2, c-neu (antibody)

RRID:AB_2099416

This monoclonal targets Generated from carboxyl terminus of human c-neu gene product

View all literature mentions

COXIV antibody (antibody)

RRID:AB_2085278

This polyclonal targets COXIV

View all literature mentions

CKB/CKM antibody (antibody)

RRID:AB_2080878

This polyclonal targets CKB/CKM

View all literature mentions

CKMT1A antibody (antibody)

RRID:AB_2081073

This polyclonal targets CKMT1A

View all literature mentions

Monoclonal Anti-c-Abl antibody produced in mouse (antibody)

RRID:AB_258262

This monoclonal targets c-Abl antibody produced in mouse

View all literature mentions

ImageJ (software resource)

RRID:SCR_003070

Open source Java based image processing software program designed for scientific multidimensional images. ImageJ has been transformed to ImageJ2 application to improve data engine to be sufficient to analyze modern datasets.

View all literature mentions

NOD.Cg-Prkdcscid Il2rg/SzJ (organism)

RRID:IMSR_JAX:005557

Mus musculus with name NOD.Cg-Prkdcscid Il2rg/SzJ from IMSR.

View all literature mentions